A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor
Clinical trial NCT05372367 · COMPLETED
Trial details
- NCT number
- NCT05372367
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-11
- Primary completion
- 2024-07-17
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.